Corvus Pharmaceuticals
CRVS
CRVS
35 hedge funds and large institutions have $68.9M invested in Corvus Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 12 closing their positions.
Holders
35
Holders Change
-10
Holders Change %
-22.22%
% of All Funds
0.77%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
3
Increased
14
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$2.87M |
2 |
CA
2
CHI Advisors
New York
|
$1.18M |
3 |
BI
3
BVF Inc
San Francisco,
California
|
$9.17M |
4 |
O
4
OrbiMed
New York
|
$20.4M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$1.73M |